
A randomised phase II study of pemetrexed versus pemetrexed + erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Non-squamous; Second-line therapy; Pemetrexed; Erlotinib;